Related Experiment Video
Updated: Oct 1, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
[Cryoglobulinemic vasculitis]
Christof Specker1, Denise Passens2, Jörg Schlaak3
1Klinik für Rheumatologie & Klinische Immunologie, Evangelisches Krankenhaus, Kliniken Essen-Mitte, Pattbergstr. 1-3, 45239, Essen, Deutschland. c.specker@kem-med.com.
Cryoglobulinemic vasculitis is a rare small vessel disease diagnosed by detecting cryoglobulins (CG). Laboratory testing requires maintaining blood samples at 37°C to prevent protein precipitation.
Area of Science:
- Immunology
- Rheumatology
- Hematology
Background:
- Cryoglobulinemic vasculitis (CV) is a rare immune complex disease affecting small blood vessels.
- Characterized by the presence of cryoglobulins (CG), serum proteins precipitating at low temperatures.
- Laboratory diagnosis is challenging due to the need for continuous sample temperature maintenance at 37°C.
Purpose of the Study:
- To provide a comprehensive overview of cryoglobulinemic vasculitis.
- To discuss the classification, causes, diagnostic challenges, and treatment strategies for CV.
- To highlight the importance of identifying and treating underlying conditions.
Main Methods:
- Review of existing literature on cryoglobulinemic vasculitis.
- Analysis of cryoglobulin classification (Types I-III) and associated conditions.
- Discussion of diagnostic laboratory requirements and therapeutic approaches.
Main Results:
- Cryoglobulins are classified into three types (I-III), each linked to specific diseases.
- Common causes include hematological, virological (most commonly Hepatitis C), and autoimmune diseases.
- Effective treatment necessitates addressing the underlying disease, with antiviral therapy for Hepatitis C offering a potential cure.
Conclusions:
- Cryoglobulinemic vasculitis requires careful laboratory handling to ensure accurate diagnosis.
- Treatment focuses on managing the underlying cause and immunosuppression to prevent organ damage.
- Early diagnosis and management of associated conditions are crucial for patient outcomes.
More Related Videos
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Related Concept Videos
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Nephrotic Syndrome I : Introduction
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Myocarditis II: Clinical Features and Diagnostic Tests